$65.73
-0.52 (-0.78%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+64.98%
1Y
+154.77%
YTD
+57.29%
Open$64.82
Previous Close$66.25
Day High$66.70
Day Low$63.75
52W High$75.50
52W Low$23.65
Volume—
Avg Volume1.02M
Market Cap5.39B
P/E Ratio—
EPS$-2.34
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$47.74
Above
SMA 200
$36.07
Above
RSI (14)
57.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
22 analysts
Price Target
-45.3% upside
Current
$65.73
$65.73
Target
$35.94
$35.94
$23.54
$35.94 avg
$41.91
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 4.61M | 3.43M | 1.61B |
| Net Income | -183,690,468 | -239,151,834 | -285,460,132 |
| Profit Margin | -3,985.0% | -7,343.0% | -17.7% |
| EBITDA | -216,025,494 | -328,687,347 | -344,556,820 |
| Free Cash Flow | — | — | -296,727,069 |
| Rev Growth | +176.6% | -52.1% | +15.2% |
| Debt/Equity | 0.00 | — | 0.66 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.93 | +0.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $352.99 | +1.72% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.88 | +0.66% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $478.81 | +2.22% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $626.31 | +1.34% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $300.33 | +4.22% | 64.3 | 37.13B |